Incidence of Stent Thrombosis With Bioresorbable Vascular Scaffolds in Comparison With Drug-Eluting Stents

被引：1
|
作者：
Messori, Andrea [1 ]
机构：
[1] Reg Hlth Syst, HTA Unit, ESTAR Toscana, Via San Salvi 12, I-50100 Florence, Italy
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 07期
关键词：
CORONARY-ARTERY-DISEASE;
D O I：
10.1016/j.jacc.2015.10.101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：891 / 892
页数：4
相关论文
共 50 条
  • [1] REPLY: Incidence of Stent Thrombosis With Bioresorbable Vascular Scaffolds in Comparison With Drug-Eluting
    Gao, Runlin
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (07) : 892 - 894
  • [2] Stent thrombosis in patients with drug-eluting stents and bioresorbable vascular scaffolds: the feared complication
    Kerkmeijer, Laura S.
    Tenekecioglu, Erhan
    Wykrzykowska, Joanna J.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (01): : 52 - 59
  • [3] Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents
    Cassese, Salvatore
    Hoppmann, Petra
    Kufner, Sebastian
    Byrne, Robert A.
    Wiebe, Jens
    Colleran, Roisin
    Giacoppo, Daniele
    Harada, Yukinori
    Laugwitz, Karl-Ludwig
    Schunkert, Heribert
    Fusaro, Massimiliano
    Kastrati, Adnan
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (08)
  • [4] Incidence and correlates of cumulative stent thrombosis with drug-eluting stents
    Kuchulakanti, PK
    Wolfram, R
    Torguson, R
    Bui, A
    Gevorkian, N
    Xue, ZY
    Satler, L
    Kent, K
    Lindsay, J
    Waksman, R
    CIRCULATION, 2005, 112 (17) : U749 - U749
  • [5] Stent thrombosis and drug-eluting stents
    Takayama, Tadateru
    Hiro, Takafumi
    Hirayama, Atsushi
    JOURNAL OF CARDIOLOGY, 2011, 58 (02) : 92 - 98
  • [6] Coronary Bifurcations: Still the Touchstone of Drug-eluting Stents and Bioresorbable Vascular Scaffolds?
    von Birgelen, Clemens
    van Houwelingen, K. Gert
    Lam, Ming Kai
    REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (10): : 787 - 789
  • [7] A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds
    Waksman, Ron
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2017, 84 : E20 - E24
  • [8] Stent thrombosis in the drug-eluting stents era: Incidence, predictors, mechanisms
    Joner, M.
    Finn, A. V.
    Farb, A.
    Ladich, E.
    Kolodgie, F. D.
    Skorija, K.
    Gold, H. K.
    Virmani, R.
    EUROPEAN HEART JOURNAL, 2006, 27 : 154 - 154
  • [9] Drug-eluting stents and late stent thrombosis
    Webster, Markw W. I.
    Ormiston, John A.
    LANCET, 2007, 370 (9591): : 914 - 915
  • [10] The safety profile of bioresorbable scaffolds in comparison with drug-eluting stents in clinical trials
    Barth U.
    Der Kardiologe, 2018, 12 (5): : 356 - 367
12345